Boston Trust Walden Corp boosted its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 2.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 845,911 shares of the semiconductor company’s stock after buying an additional 19,579 shares during the quarter. Boston Trust Walden Corp owned approximately 2.63% of Axcelis Technologies worth $58,952,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its holdings in Axcelis Technologies by 50.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 481 shares of the semiconductor company’s stock worth $34,000 after buying an additional 161 shares during the period. Parallel Advisors LLC lifted its stake in shares of Axcelis Technologies by 129.0% in the 2nd quarter. Parallel Advisors LLC now owns 545 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 307 shares during the period. Fifth Third Bancorp lifted its stake in shares of Axcelis Technologies by 160.5% in the 1st quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 358 shares during the period. Bayforest Capital Ltd acquired a new position in shares of Axcelis Technologies in the 1st quarter valued at about $38,000. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Axcelis Technologies by 97.5% in the 1st quarter. Nisa Investment Advisors LLC now owns 796 shares of the semiconductor company’s stock valued at $40,000 after purchasing an additional 393 shares during the period. 89.98% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Axcelis Technologies in a research note on Wednesday, October 8th. B. Riley boosted their price objective on Axcelis Technologies from $58.00 to $75.00 and gave the company a “neutral” rating in a research note on Wednesday, June 18th. Zacks Research downgraded Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Bank of America downgraded Axcelis Technologies from a “neutral” rating to an “underperform” rating and upped their price target for the stock from $81.00 to $90.00 in a research note on Monday. Finally, Benchmark raised Axcelis Technologies from a “hold” rating to a “buy” rating and set a $105.00 price target on the stock in a research note on Thursday, October 2nd. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $97.00.
Axcelis Technologies Stock Performance
ACLS stock opened at $81.43 on Tuesday. The firm has a market cap of $2.56 billion, a PE ratio of 16.65 and a beta of 1.75. The company has a quick ratio of 4.26, a current ratio of 6.01 and a debt-to-equity ratio of 0.04. The business has a 50 day moving average of $85.35 and a 200-day moving average of $69.46. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $107.23.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last released its earnings results on Monday, April 21st. The semiconductor company reported $1.71 earnings per share (EPS) for the quarter. The company had revenue of $252.42 million during the quarter. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%. As a group, sell-side analysts expect that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Congress Is Buying Intuitive Surgical Ahead of Earnings
- 5 Top Rated Dividend Stocks to Consider
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Should You Invest in Penny Stocks?
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.